The completion of two seasons of RSV immunization for infants provides us with an opportunity to reflect on ways to enhance policies, programs, and systems to maximize protection for infants. Successful national implementation of an RSV infant immunization program hinges on a coordinated, multi-faceted approach that includes raising awareness, enhancing provider education, ensuring accessibility, and fostering collaboration across various sectors. While we have made progress, there are opportunities to close remaining gaps. This panel will provide perspectives across policy, patient advocacy, and implementation to identify best practices to drive public health impact with these new strategies even as new preventive options become available. Sponsored by: Merck